Alnylam Pharmaceuticals
Reports from Alnylam Pharmaceuticals present the latest news and research developments
Published in Lab Business Week, November 19th, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Alnylam Pharmaceuticals.
Report 1: Alnylam Pharmaceuticals, Inc., (ALNY) announced that Vincent Miles, PhD, senior VP, Business Development, is planning to leave the company to pursue his interests in other areas.
He will remain with Alnylam on a full-time basis through the end of the year and will then work through a transition period as the company identifies a replacement. After almost thirty years of employment in the biotechnology...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-11-19)
More Articles from Lab Business Week
- Breast Cancer
Lawrence Berkeley reports tissue geometry plays crucial role in breast cell invasion - Business Update
Eaton Laboratories issues corrected record date for spinoff of subsidiary - Business Update
Micro-Virology Labs announces availability of disinfectant tests for biopharma industry - Business Update
Willow Laboratories participates in U.S. Department of Labor's drug-free work week - Escherichia coli
Reports from Wellcome Trust Research Laboratories highlight recent research in escherichia coli - Genetics & Genomics
Research from Wellcome Trust Research Laboratories in the area of genetics & genomics published - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
